Article
A novel SPINK5 mutation and successful subcutaneous immunoglobulin replacement therapy in a child with Netherton syndrome.
Pediatric dermatology - 1 Nov 2020
Zelieskova Maria, Banovcin Peter, Kozar Marek, Kozarova Andrea, Nudzajova Zuzana, Jesenak Milos
Abstract excerpt
We report a 2-year-old patient with Netherton syndrome presenting with generalized exfoliative erythroderma, ichthyosiform dermatitis, trichorrhexis invaginata, hypernatremic dehydration, failure to thrive, and recurrent respiratory infections. Molecular analysis of SPINK5 identified a novel mutation (c.1530CA). Our case report also verifies and supports the safety and efficacy of subcutaneous immunoglobulin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
